Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05649241 · ClinicalTrials.gov registry record · NA
QuitAid Pilot Feasibility Trial
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT05649241: Completed NA study, sponsored by University of Virginia.
NCT05649241 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05649241, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Adult smokers were recruited through an independent pharmacy in rural Appalachia and were randomized to 1 of 8 treatments, including medication and/or therapy from the pharmacist, to help quit smoking.
Primary Outcome
Feasibility of recruitment was measured by (a) the proportion of smokers recruited from each source (e.g., ask-advise-connect, posters, prescription bag advertisements) and (b) the number recruited per month.
Interventions
- DRUG Nicotine gum
- DRUG Nicotine patch
- BEHAVIORAL Medication Therapy Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-08-31 |
| Est. Completion | 2022-10-19 |
| Phase | NA |
What the finished NCT05649241 record still lists
NCT05649241 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Nicotine gum is the first listed.
NCT05649241 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05649241 about?
NCT05649241 is a clinical study titled "QuitAid Pilot Feasibility Trial". Adult smokers were recruited through an independent pharmacy in rural Appalachia and were randomized to 1 of 8 treatments, including medication and/or therapy from the pharmacist, to help quit smoking.
What is the current status of trial NCT05649241?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-08-31. Estimated completion is 2022-10-19.
What interventions are being tested in trial NCT05649241?
The interventions under investigation include: Nicotine gum (DRUG), Nicotine patch (DRUG), Medication Therapy Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT05649241?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05649241's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI